Abcam Reports & Presentations

2018 Reports

Interim results presentation for the half-year ending 31 Dec 2017
Interim report for half-year ending 31 Dec 2017
36th Annual JP Morgan Healthcare Conference Presentation

2017 Reports

Annual report for the year ending 30 June 2017
Preliminary results presentation for the year ending June 2017
Preliminary results for year ending June 2017
Interim report for half-year ending 31 Dec 2016
35th Annual JP Morgan Healthcare Conference Presentation

2016 Reports

Preliminary results for year ending 30 June 2016
Interim report for half-year ending 31 Dec 2015

2015 Reports

Preliminary results for year ending 30 June 2015
Interim report for half-year ending 31 Dec 2014

2014 Reports

Preliminary results for year ending 30 June 2014
Interim report for half-year ending 31 Dec 2013

2013 Reports

Preliminary results for year ending 30 June 2013
Interim report for half-year ending 31 Dec 2012

2012 Reports

Preliminary results for year ending 30 June 2012
Interim results for half-year ending 31 Dec 2011

2011 Reports

Preliminary results for year ending 30 June 2011
Interim results for half-year ending 31 Dec 2010

2010 Reports

Preliminary results for year ending 30 June 2010
Interim results for half-year ending 31 Dec 2009

2009 Reports

Preliminary results for year ending 30 June 2009
Interim results for half-year ending 31 Dec 2008

2008 Reports

Preliminary results for year ending 30 June 2008
Interim results for half-year ending 31 Dec 2007

2007 Reports

Preliminary results for year ending 30 June 2007
Interim results for half-year ending 31 Dec 2006

2006 Reports

Preliminary results for year ending 30 June 2006
Interim results for half-year ending 31 Dec 2005

2005 Reports

Preliminary results for year ending 30 June 2005

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +